A Category That Crossed the Mainstream Threshold

China's health snacks and edibles market reached CN¥159.8 billion in 2025, growing 27.3% year on year — a pace that leaves little doubt about the structural nature of this shift. This is not a supplements boom driven by a single fad ingredient or a pandemic-era health spike that fades once consumer anxiety subsides. According to Moojing Market Intelligence analysis spanning December 2023 to March 2026, every single quarter of 2025 outperformed its equivalent quarter in 2024, with sales crossing the CN¥40 billion per quarter mark beginning in Q2 and holding that elevated base through year-end.

The category is now firmly bifurcated. Modern supplements — comprising vitamins, probiotics, collagen, protein powders, fish oil, and functional gummies — account for CN¥121.0 billion, or roughly 76% of total market value. Traditional tonic foods — bird's nest, ginseng, ejiao, wolfberry, and herbal preparations — contribute CN¥38.8 billion, growing from a smaller base but reflecting persistent demand for occasion-driven, family-care purchases. Both segments are expanding simultaneously, which reveals something important: this market is not cannibalizing one format at the expense of another. It is expanding the overall addressable population of health-conscious consumers.

Format Is the New Formulation

The most consequential strategic insight from China's 2025 data is not about which health claims are trending — it is about how supplements are being delivered. The category's growth is structurally correlated with a shift away from tablets and hard capsules (still CN¥40B in annual sales) toward formats that lower behavioral friction: gummies (CN¥30B), powders and sachets (CN¥20B), protein powders (CN¥15B), and ready-to-drink formats (CN¥8B).

The logic is straightforward. A supplement gummy behaves like a snack. A morning sachet dissolved in water behaves like coffee. A collagen drink fits the same slot as a sparkling beverage. When health consumption stops requiring a conscious act of discipline and starts resembling an enjoyable daily ritual, compliance improves — and with compliance comes repeat purchase, the single most important metric for any consumable brand.

Growth momentum by format tells a sharper story. Moojing's directional growth index places anti-aging capsules at 3x the stable baseline, followed by children's chewables (2.2x). Gummies, fresh tonics, and softgels all show meaningful acceleration above baseline. Tablets, though still the largest format in absolute value, sit at the stable baseline — suggesting saturation rather than growth. For product developers, the implication is clear: the investment case is in formats that remove friction and attach clearly to a life stage or identity.

Sleep and Weight Control: The Two Dominant Demand Signals

When Moojing mapped social post volumes across major health topics, two categories separated themselves decisively from the field: weight control at 24.8 million posts and sleep health at 24.3 million posts. The next largest topic — functional food — registered just 6.5 million. Gut health and collagen beauty each came in near 6.4 million and 4.9 million respectively.

More telling than the volume data is the trajectory. Sleep health posts grew 17% in 2025 — making it not just a large conversation but the fastest-accelerating topic in the dataset. Weight control grew at 7%. What this means is that gut health and collagen are mature, understood categories where consumer awareness is stable and the marketing challenge is differentiation rather than education. Sleep, by contrast, is a category still in the phase of rapid awareness build — where first-mover brands can establish authority before the conversation saturates.

The commercial logic of sleep as a category anchor is well established globally, from the mainstreaming of melatonin in North America to adaptogen-forward beverage brands like Recess and Driftwell. China is now running the same transition at significantly greater scale. For MENA brands and investors watching this space, the signal is relevant: sleep-focused functional products — gummies, warm drinks, sachets designed for bedtime — represent the category with the widest gap between current supply and emerging consumer intent.

Consumers Buy Routines, Not Products

Perhaps the most strategically underappreciated finding in Moojing's report is the review theme analysis. When Chinese consumers write product reviews for health snacks and supplements, the most discussed topic — by a wide margin — is not the ingredient list, not the health function, not even the brand. It is use occasion, with 5.19 million mentions. Product type comes second at 2.69 million, followed by target consumer at 2.40 million. Taste sits last at just 0.58 million — not because taste doesn't matter (it clearly does for repeat purchase), but because consumers appear to discuss it more in complaints than in reviews.

The implication for product strategy is profound. Consumers entering this category are not asking "what does this ingredient do?" They are asking: "When do I take this? How does it fit into my morning? My kid's lunch box? My bedtime routine?" The winning positioning framework is therefore temporal and behavioral, not functional and clinical. Brands that lead with a clearly defined moment of consumption — rather than an EBITDA-optimized claims hierarchy — will build more durable habit loops.

The Complaint Map: Where Brands Are Losing Repurchase

Demand is not the problem in China's health snack market. The barriers to growth are operational and communication-related — and they are largely fixable. Moojing's complaint analysis reveals that 17% of gut-product reviews express result-related skepticism — consumers who took a probiotic sachet for two weeks and couldn't identify a clear outcome. Weight product complaints register at 7%. Taste and trust concerns sit at 3% each, with pack value at 2%.

These numbers describe a trust gap, not a demand gap. Consumers are purchasing these products — but at the moment of repurchase decision, uncertainty about what they actually experienced creates hesitation. The solution is not stronger health claims (which would widen the credibility gap) but clearer expectation-setting: specific timing guidance, progressive result milestones, and honest, quantified benefit communication. The brands that solve this will have structural advantages in lifetime value and subscription conversion.

The Price Architecture Problem

One structural tension worth examining is the pricing distribution. Despite the narrative of a premium health food boom, 68% of modern supplement sales in China still sit in the entry price band. Mid-low captures 15%. Premium and ultra-premium combined account for just 9% of sales. This suggests the category remains volume-driven at the accessible end of the price spectrum — which is not a weakness, but it does reframe the opportunity for international or specialized brands seeking to compete on quality rather than price.

Premiumization is a viable path, but the data indicates it requires a credible premium justification — not aesthetic packaging alone. Stronger active ingredient concentrations, clinical sourcing transparency, superior taste profiles, and more convenient formats are the levers that Chinese consumers have demonstrated willingness to pay for. Generic premiumization — a higher price point on a similar product in a glossier box — faces structural resistance in a category where 68% of buyers are entry-price anchored.

What This Means for MENA and Saudi Arabia

China's functional food trajectory is not an isolated national story — it is a directional signal for markets at similar stages of wellness consumer development. Saudi Arabia and the wider Gulf region are witnessing structurally parallel conditions: rising rates of lifestyle-related health concerns, a young and digitally-engaged consumer population, significant government investment in preventive health infrastructure, and an e-commerce ecosystem increasingly capable of sustaining subscription-model wellness brands.

The Saudi nutraceuticals and health food market is growing, but remains early-stage relative to its potential. Supplement retail has historically been concentrated in pharmacy channels and international imports, with limited domestic innovation in formats or positioning. The opportunity that China's data makes legible is this: the brands that define occasion-led, format-optimized health routines for Gulf consumers — before category saturation — will hold structural advantages that are difficult for later entrants to displace.

Vision 2030's health and wellness agenda creates favorable regulatory and investment conditions for this category. The Kingdom's Quality of Life Program, coupled with expanding health insurance coverage and rising consumer health literacy, is accelerating the conditions under which functional food becomes a mainstream consumer behavior rather than a niche wellness indulgence. Saudi food companies, CPG manufacturers, and investors with long positioning horizons should be reading China as a 3-to-5 year leading indicator for their own market.

Editorial View

The Moojing report's core insight is deceptively simple: health products get repurchased when they fit into a consumer's life like a natural habit. The sophistication lies in what that requires from a brand — not just a strong ingredient stack or a compelling health claim, but a clear moment of consumption, a format that removes effort, and communication that sets honest expectations. China's CN¥159.8 billion market has proven the demand. The question for every market watching this shift is whether they can build the supply infrastructure, regulatory clarity, and brand communication sophistication to capture it. For Saudi Arabia, the window remains open — and the playbook has now been written at scale.